Related Experiment Video
Updated: Apr 18, 2026
05:20
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
3.3K
ABC transporters and neuroblastoma
Denise M T Yu1, Tony Huynh1, Alan M Truong1
1Lowy Cancer Research Centre, Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia.
Advances in Cancer Research
|February 3, 2015
Summary
High-risk neuroblastoma survival is poor, but targeting MYCN-regulated transporters like ABCC1 and ABCC4 may offer new therapeutic strategies. These transporters influence cancer progression through endogenous substrates, not just drug efflux.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Neuroblastoma is a leading cause of childhood cancer death, with high-risk cases having poor survival rates.
- MYCN oncogene amplification is a key driver of aggressive neuroblastoma.
- ATP-binding cassette (ABC) transporters, including ABCC1, ABCC3, and ABCC4, are direct MYCN targets and are implicated in neuroblastoma prognosis.
Purpose of the Study:
- To investigate the role of MYCN-regulated ABC transporters (ABCC1, ABCC3, ABCC4) in high-risk neuroblastoma.
- To explore the potential of these transporters as therapeutic targets, considering both drug efflux and endogenous substrate roles.
- To evaluate the prognostic significance of ABCC1, ABCC3, and ABCC4 in neuroblastoma.
Main Methods:
- Analysis of MYCN transcriptional targets, focusing on ABC transporter gene expression.
- Prognostic evaluation of ABCC1, ABCC3, and ABCC4 in primary neuroblastoma cohorts.
- Investigation into the role of endogenous substrates (prostaglandins, leukotrienes) of ABCC1 and ABCC4 in cancer biology.
Main Results:
- ABCC1, ABCC3, and ABCC4 expression levels are strongly prognostic for neuroblastoma outcome.
- These transporters contribute to neuroblastoma progression independently of their role in chemotherapeutic drug resistance.
- Endogenous substrates like prostaglandins and leukotrienes, transported by ABCC1 and ABCC4, influence key cancer processes.
Conclusions:
- ABCC1 and ABCC4 are significant therapeutic targets for high-risk neuroblastoma.
- Small-molecule inhibitors targeting these transporters may offer a novel treatment strategy for aggressive neuroblastoma and other cancers.
- Understanding the role of endogenous substrates is crucial for developing effective therapies targeting these ABC transporters.
Related Concept Videos
01:31ABC Transporters: Exporter
7.3K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
7.3K
01:27ABC Transporters: Importer
3.8K
ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
3.8K
01:14Active Transport
2.8K
Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
2.8K
01:06Carrier-Mediated Transport
1.6K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
01:31Membrane Transporters
20.1K
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
20.1K
01:27Glucose Transporters
28.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.5K